Measles in HIV-infected children in southern Africa

References

• Progress report of the national response to the 2001 declaration of commitment on HIV and AIDS. Botswana country report 2010 (Reporting Period: 2008–2009) UNAIDS [document on the Internet]. c2010. Available from: http://www.unaids.org/en/dataanalysis/monitoringcountryprogress/2010progressreportssubmittedbycountries/botswana_2010_country_progress_report_en.pdf (Accessed 10/12/10).
   Google Scholar
• Chatterjee MT, Coleman M, Brook G, McCrea D. Measles mimicking HIV seroconversion syndrome: a case report. J Med Case Reports. 2010;4:41.
   PubMedGoogle Scholar
• Moss WJ, Fisher C, Scott S, et al. HIV type 1 infection is a risk factor for mortality in hospitalized Zambian children with measles. Clin Infect Dis. 2008;46:523–527.
   PubMed Web of Science ®Google Scholar
• Piastra M, Onesimo R, De Luca D, et al. Measles-induced respiratory distress, air-leak and ARDS. Eur J Clin Microbiol Infect Dis. 2009;29:181–185.
   PubMed Web of Science ®Google Scholar
• Moss WJ, Cutts F, Griffin DE. Implications of the human immunodeficiency virus epidemic for control and eradication of measles. Clin Infect Dis. 1999;29:106–112.
   PubMed Web of Science ®Google Scholar
• Nair N, Moss WJ, Scotts, et al. HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection. J Infect Dis. 2009;200:1031–1038.
   PubMed Web of Science ®Google Scholar
• Moss WJ, Scott S, Mugala N, et al. Immunogenicity of standard-titer measles vaccine in HIV 1-infected and uninfected Zambian children: an observational study. J Infect Dis. 2007;196:347–355.
   PubMed Web of Science ®Google Scholar
• Abramson O, Dagan R, Tal A, Sofer S. Severe complications of measles requiring intensive care in infants and young children. Arch Pediatr Adolesc Med. 1995;149(11):1237–1240.
   PubMed Web of Science ®Google Scholar
• Hussey G, Simpson J. Nosocomial bacteremias in measles. Pediatr Infect Dis J. 1990;10:715–717.
   Web of Science ®Google Scholar
• Perry R, Mmiro F, Ndugwa C, Semba R. Measles infection in HIV-infected African infants. Ann N Y Acad Sci. 2006;918:1:377–380.
   Google Scholar
• Sension MG, Quinn T, Markowitz LE, et al. Measles in hospitalized children infected with human immunodeficiency virus. Am J Dis Child. 1988;142:1271–1272.
   PubMedGoogle Scholar
• Oshitani H, Suzuki H, Mpabalwani ME, et al. Measles case fatality by sex, vaccination status, and HIV-1 antibody in Zambian children. Lancet 1996;348:415.
   PubMed Web of Science ®Google Scholar
• Moss WJ, Monze M, Ryon JJ, et al. Prospective study of measles in hospitalized human immunodeficiency virus HIV-infected and HIV-uninfected children in Zambia. Clin Infect Dis. 2002;35:189–196.
   PubMed Web of Science ®Google Scholar
• Schaible, U, Kaufmann S. Malnutrition and infection: complex mechanisms and global impacts. PLoS Med. 2007;4(5):e115.
   PubMed Web of Science ®Google Scholar
• Katona P, Katona-Apte J. The interaction between nutrition and infection. Clin Infect Dis. 2008:46:1582–1588.
   Google Scholar
• Hsu J, Pencharz P, Macallan D, Tomkins A. Macronutrients and HIV/AIDS: a review of current evidence. Consultation on nutrition and HIV/AIDS in Africa: evidence, lessons and recommendations for action. Geneva: World Health Organization Department of Nutrition for Health and Development; 2005.
   Google Scholar
• Grais RF, Dubray C, Gerstl S, et al. Unacceptably high mortality related to measles epidemics in Niger, Nigeria and Chad. PLoS Med. 2007 Jan;4(1):e16.
   PubMed Web of Science ®Google Scholar
• Scott S, Mossong J, Moss W, et al. Predicted impact on the HIV-1 epidemic on measles in developing countries: results from a dynamic age—structured model. Int J Epidemiol. 2008;37:356–367.
   PubMed Web of Science ®Google Scholar
• Helfand, R, Witte E, Fowlkes A, et al. Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi. J Infect Dis. 2008;198:1457–1465.
   PubMed Web of Science ®Google Scholar
• Helfand R, Moss WJ, Harpaz R, et al. Evaluating the impact of the HIV pandemic on measles control and elimination. Bull World Health Organ. 2005;83:329–337.
   PubMed Web of Science ®Google Scholar
• Permar SR, Moss WJ, Ryon JJ, et al. Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction. J Infect Dis. 2001;183:532–538.
   PubMed Web of Science ®Google Scholar
• Ceyhan, M, Kanra, G, Erdem, G, Kanra, B. Immunogenicity and efficacy of one-dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age. Vaccine 2001;19:31:4473–4478
   PubMed Web of Science ®Google Scholar
• World Health Organization. Measles vaccines: WHO position paper. Weekly Epidemiological Record. Geneva: 2009;84:349–360.
   Google Scholar
• Caceres VM, Strebel PM, Sutter RW. Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. Clin Infect Dis. 2000;31:110–119.
   PubMed Web of Science ®Google Scholar
• The United Nations Children's Fund country statistics: Botswana [homepage on the Internet]. c2010. Available from http://www.unicef.org/infobycountry/botswana_statistics.html
   Google Scholar